miR-383-5p, miR-181a-5p and miR-181b-5p as predictors of response to first-generation somatostatin receptor ligands in ac-romegaly

Mirnome of Ten patients with acromegaly in treatment with first-generation somatostatin receptor ligands (fg-SRLs): five controlled and five uncontrolled by fg-SRLs treatment. Controlled patients was were defined as GH < 1.0 ng/mL and normal IGF-I adjusted for age.

本数据集包含10例接受第一代生长抑素受体配体（fg-SRLs）治疗的肢端肥大症患者的微小RNA组（miRNome）数据：其中5例患者经fg-SRLs治疗后病情得到控制，5例未获控制。病情得到控制的患者定义为生长激素（GH）水平＜1.0 ng/mL，且年龄校正后的胰岛素样生长因子1（IGF-I）水平处于正常范围。